The Hippo Tumor Suppressor Network: From Organ Size Control to Stem Cells and Cancer (E2)
May 19 - 23, 2013
Monterey, California, USA

June 2013

Human Genomics and Personalized Medicine (E3)
June 17 - 21, 2013
Stockholm, Sweden  

October 2013

Advancing Vaccines in the Genomics Era (T1)
October 31 - November 4, 2013
Rio de Janeiro, Brazil  

January 2014

Sensing and Signaling of Hypoxia: Interfaces with Biology and Medicine (A1)
January 7 - 12, 2014
Breckenridge, Colorado, USA The Ubiquitin System: From Basic Science to Drug Discovery (A2)
January 7 - 12, 2014
Big Sky, Montana, USA Nuclear Receptors: Biological Networks, Genome Dynamics and Disease (A3)
January 10 - 15, 2014
Taos, New Mexico, USA Tissue-Resident Memory T Cells (A4)
January 12 - 16, 2014
Snowbird, Utah, USA Aging - Pushing the Limits of Cellular Quality Control (A5)
January 12 - 17, 2014
Steamboat Springs, Colorado, USA Challenges and Opportunities in Diabetes Research and Treatment (J1)
January 12 - 17, 2014
Vancouver, British Columbia, Canada Obesity: A Multisystems Perspective (J2)
January 12 - 17, 2014
Vancouver, British Columbia, Canada Emerging Cytokine Networks (J3)
January 17 - 22, 2014
Vancouver, British Columbia, Canada Inflammatory Diseases: Recent Advances in Basic and Translational Research and Therapeutic Treatments (J4)
January 17 - 22, 2014
Vancouver, British Columbia, Canada Pathogenesis of Respiratory Viruses (J5)
January 19 - 24, 2014
Keystone, Colorado, USA Innate Immunity to Viral Infections (J6)
January 19 - 24, 2014
Keystone, Colorado, USA New Frontiers in the Discovery and Treatment of Thrombosis (A6)
January 26 - 30, 2014
Keystone, Colorado, USA Mechanisms and Consequences of Invertebrate-Microbe Interactions (A7)
January 26 - 30, 2014
Tahoe City, California, USA Growth and Wasting in Heart and Skeletal Muscle (A8)
January 26 - 31, 2014
Santa Fe, New Mexico, USA RNA Silencing (A9)
January 31 - February 5, 2014
Seattle, Washington, USA  

February 2014

The Science of Malaria Eradication (F1)
February 2 - 7, 2014
Merida, Yucatan, Mexico Developmental Pathways and Cancer: Wnt, Notch and Hedgehog (J7)
February 2 - 7, 2014
Banff, Alberta, Canada Stem Cells and Cancer (J8)
February 2 - 7, 2014
Banff, Alberta, Canada Cancer Epigenetics (Q1)
February 4 - 9, 2014
Santa Fe, New Mexico, USA Transcriptional Regulation (Q2)
February 4 - 9, 2014
Santa Fe, New Mexico, USA Plant Signaling: Dynamic Properties (B1)
February 5 - 10, 2014
Breckenridge, Colorado, USA Molecular Cell Biology of Macrophages in Human Diseases (B2)
February 9 - 14, 2014
Santa Fe, New Mexico, USA Prophylactic and Therapeutic Antibodies (Q3)
February 9 - 14, 2014
Keystone, Colorado, USA Biology of B Cell Responses (Q4)
February 9 - 14, 2014
Keystone, Colorado, USA Omics Meets Cell Biology: Applications to Human Health and Disease (B3)
February 18 - 23, 2014
Taos, New Mexico, USA Mitochondrial Dynamics and Physiology (Q5)
February 18 - 23, 2014
Santa Fe, New Mexico, USA The Chemistry and Biology of Cell Death (Q6)
February 18 - 23, 2014
Santa Fe, New Mexico, USA The NF-kappaB System in Health and Disease (B4)
February 23 - 28, 2014
Keystone, Colorado, USA Long Noncoding RNAs: Marching toward Mechanism (B5)
February 27 - March 4, 2014
Santa Fe, New Mexico, USA  

March 2014

Cilia, Development and Human Disease (C1)
March 2 - 7, 2014
Tahoe City, California, USA Parkinson’s Disease: Genetics, Mechanisms and Therapeutics (Q7)
March 2 - 7, 2014
Keystone, Colorado, USA Alzheimer’s Disease – From Fundamental Insights to Light at the End of the Translational Tunnel (Q8)
March 2 - 7, 2014
Keystone, Colorado, USA Mobile Genetic Elements and Genome Evolution (C2)
March 9 - 14, 2014
Santa Fe, New Mexico, USA Inflammation, Infection and Cancer (X1)
March 9 - 14, 2014
Whistler, British Columbia, Canada Immune Evolution in Cancer (X2)
March 9 - 14, 2014
Whistler, British Columbia, Canada HIV Vaccines: Adaptive Immunity and Beyond (X3)
March 9 - 14, 2014
Banff, Alberta, Canada HIV Pathogenesis - Virus vs. Host (X4)
March 9 - 14, 2014
Banff, Alberta, Canada Metabolism and Angiogenesis (X5)
March 16 - 21, 2014
Whistler, British Columbia, Canada Tumor Metabolism (X6)
March 16 - 21, 2014
Whistler, British Columbia, Canada Lipid Pathways in Biology and Disease (C3)
March 19 - 24, 2014
Dublin 4, Ireland Fibrosis: From Bench to Bedside (C4)
March 23 - 28, 2014
Keystone, Colorado, USA Chromatin Mechanisms and Cell Physiology (C5)
March 23 - 28, 2014
Oberstdorf , Germany Big Data in Biology (F2)
March 23 - 25, 2014
San Francisco, CA, USA Complications of Diabetes (X7)
March 23 - 28, 2014
Whistler, British Columbia, Canada Innate Immunity, Metabolism and Vascular Injury (X8)
March 23 - 28, 2014
Whistler, British Columbia, Canada The Ins and Outs of Viral Infection: Entry, Assembly, Exit and Spread (C6)
March 30 - April 4, 2014
Breckenridge, Colorado, USA Novel Therapeutic Approaches to Tuberculosis (C7)
March 30 - April 4, 2014
Keystone, Colorado, USA G Protein-Coupled Receptors: Structural Dynamics and Functional Implications (Z1)
March 30 - April 4, 2014
Snowbird, Utah, USA Frontiers of Structural Biology (Z2)
March 30 - April 4, 2014
Snowbird, Utah, USA  

April 2014

Exploiting and Understanding Chemical Biotransformations in the Human Microbiome (D1)
April 1 - 6, 2014
Big Sky, Montana, USA Epigenetic Programming and Inheritance (D2)
April 6 - 10, 2014
Boston, Massachusetts, USA Emerging Concepts and Targets in Islet Biology (D3)
April 6 - 11, 2014
Keystone, Colorado, USA Engineering Cell Fate and Function (Z3)
April 6 - 11, 2014
Olympic Valley, CA, USA Stem Cells and Reprogramming (Z4)
April 6 - 11, 2014
Olympic Valley, CA, USA  

May 2014

Adult Neurogenesis (E1)
May 12 - 17, 2014
Stockholm, Sweden Autophagy: Fundamentals to Disease (E2)
May 23 - 28, 2014
Austin, TX, USA  

June 2014

The Brain: Adaptation and Maladaptation in Chronic Pain (E3)
June 15 - 20, 2014
Keystone, Colorado, USA  

Biophysics

G Protein-Coupled Receptors: Structural Dynamics and Functional Implications (Z1)
March 30 - April 4, 2014
Snowbird, Utah, USA Frontiers of Structural Biology (Z2)
March 30 - April 4, 2014
Snowbird, Utah, USA  

Cancer

The Hippo Tumor Suppressor Network: From Organ Size Control to Stem Cells and Cancer (E2)
May 19 - 23, 2013
Monterey, California, USA The Ubiquitin System: From Basic Science to Drug Discovery (A2)
January 7 - 12, 2014
Big Sky, Montana, USA RNA Silencing (A9)
January 31 - February 5, 2014
Seattle, Washington, USA Developmental Pathways and Cancer: Wnt, Notch and Hedgehog (J7)
February 2 - 7, 2014
Banff, Alberta, Canada Stem Cells and Cancer (J8)
February 2 - 7, 2014
Banff, Alberta, Canada Cancer Epigenetics (Q1)
February 4 - 9, 2014
Santa Fe, New Mexico, USA Prophylactic and Therapeutic Antibodies (Q3)
February 9 - 14, 2014
Keystone, Colorado, USA Cilia, Development and Human Disease (C1)
March 2 - 7, 2014
Tahoe City, California, USA Inflammation, Infection and Cancer (X1)
March 9 - 14, 2014
Whistler, British Columbia, Canada Immune Evolution in Cancer (X2)
March 9 - 14, 2014
Whistler, British Columbia, Canada Metabolism and Angiogenesis (X5)
March 16 - 21, 2014
Whistler, British Columbia, Canada Tumor Metabolism (X6)
March 16 - 21, 2014
Whistler, British Columbia, Canada Chromatin Mechanisms and Cell Physiology (C5)
March 23 - 28, 2014
Oberstdorf , Germany G Protein-Coupled Receptors: Structural Dynamics and Functional Implications (Z1)
March 30 - April 4, 2014
Snowbird, Utah, USA Autophagy: Fundamentals to Disease (E2)
May 23 - 28, 2014
Austin, TX, USA  

Cardiovascular

Challenges and Opportunities in Diabetes Research and Treatment (J1)
January 12 - 17, 2014
Vancouver, British Columbia, Canada New Frontiers in the Discovery and Treatment of Thrombosis (A6)
January 26 - 30, 2014
Keystone, Colorado, USA Growth and Wasting in Heart and Skeletal Muscle (A8)
January 26 - 31, 2014
Santa Fe, New Mexico, USA Mitochondrial Dynamics and Physiology (Q5)
February 18 - 23, 2014
Santa Fe, New Mexico, USA Metabolism and Angiogenesis (X5)
March 16 - 21, 2014
Whistler, British Columbia, Canada Complications of Diabetes (X7)
March 23 - 28, 2014
Whistler, British Columbia, Canada Innate Immunity, Metabolism and Vascular Injury (X8)
March 23 - 28, 2014
Whistler, British Columbia, Canada  

Development

The Hippo Tumor Suppressor Network: From Organ Size Control to Stem Cells and Cancer (E2)
May 19 - 23, 2013
Monterey, California, USA New Frontiers in the Discovery and Treatment of Thrombosis (A6)
January 26 - 30, 2014
Keystone, Colorado, USA Growth and Wasting in Heart and Skeletal Muscle (A8)
January 26 - 31, 2014
Santa Fe, New Mexico, USA Developmental Pathways and Cancer: Wnt, Notch and Hedgehog (J7)
February 2 - 7, 2014
Banff, Alberta, Canada Stem Cells and Cancer (J8)
February 2 - 7, 2014
Banff, Alberta, Canada Cancer Epigenetics (Q1)
February 4 - 9, 2014
Santa Fe, New Mexico, USA Cilia, Development and Human Disease (C1)
March 2 - 7, 2014
Tahoe City, California, USA Mobile Genetic Elements and Genome Evolution (C2)
March 9 - 14, 2014
Santa Fe, New Mexico, USA Epigenetic Programming and Inheritance (D2)
April 6 - 10, 2014
Boston, Massachusetts, USA Engineering Cell Fate and Function (Z3)
April 6 - 11, 2014
Olympic Valley, CA, USA Stem Cells and Reprogramming (Z4)
April 6 - 11, 2014
Olympic Valley, CA, USA Adult Neurogenesis (E1)
May 12 - 17, 2014
Stockholm, Sweden  

Drug Discovery

The Hippo Tumor Suppressor Network: From Organ Size Control to Stem Cells and Cancer (E2)
May 19 - 23, 2013
Monterey, California, USA Challenges and Opportunities in Diabetes Research and Treatment (J1)
January 12 - 17, 2014
Vancouver, British Columbia, Canada New Frontiers in the Discovery and Treatment of Thrombosis (A6)
January 26 - 30, 2014
Keystone, Colorado, USA The Science of Malaria Eradication (F1)
February 2 - 7, 2014
Merida, Yucatan, Mexico Developmental Pathways and Cancer: Wnt, Notch and Hedgehog (J7)
February 2 - 7, 2014
Banff, Alberta, Canada Stem Cells and Cancer (J8)
February 2 - 7, 2014
Banff, Alberta, Canada Prophylactic and Therapeutic Antibodies (Q3)
February 9 - 14, 2014
Keystone, Colorado, USA Omics Meets Cell Biology: Applications to Human Health and Disease (B3)
February 18 - 23, 2014
Taos, New Mexico, USA Mitochondrial Dynamics and Physiology (Q5)
February 18 - 23, 2014
Santa Fe, New Mexico, USA Parkinson’s Disease: Genetics, Mechanisms and Therapeutics (Q7)
March 2 - 7, 2014
Keystone, Colorado, USA HIV Pathogenesis - Virus vs. Host (X4)
March 9 - 14, 2014
Banff, Alberta, Canada Tumor Metabolism (X6)
March 16 - 21, 2014
Whistler, British Columbia, Canada Fibrosis: From Bench to Bedside (C4)
March 23 - 28, 2014
Keystone, Colorado, USA Novel Therapeutic Approaches to Tuberculosis (C7)
March 30 - April 4, 2014
Keystone, Colorado, USA G Protein-Coupled Receptors: Structural Dynamics and Functional Implications (Z1)
March 30 - April 4, 2014
Snowbird, Utah, USA Exploiting and Understanding Chemical Biotransformations in the Human Microbiome (D1)
April 1 - 6, 2014
Big Sky, Montana, USA The Brain: Adaptation and Maladaptation in Chronic Pain (E3)
June 15 - 20, 2014
Keystone, Colorado, USA  

Genetics / Genomics

Human Genomics and Personalized Medicine (E3)
June 17 - 21, 2013
Stockholm, Sweden Advancing Vaccines in the Genomics Era (T1)
October 31 - November 4, 2013
Rio de Janeiro, Brazil Challenges and Opportunities in Diabetes Research and Treatment (J1)
January 12 - 17, 2014
Vancouver, British Columbia, Canada New Frontiers in the Discovery and Treatment of Thrombosis (A6)
January 26 - 30, 2014
Keystone, Colorado, USA Mechanisms and Consequences of Invertebrate-Microbe Interactions (A7)
January 26 - 30, 2014
Tahoe City, California, USA Cancer Epigenetics (Q1)
February 4 - 9, 2014
Santa Fe, New Mexico, USA Plant Signaling: Dynamic Properties (B1)
February 5 - 10, 2014
Breckenridge, Colorado, USA Omics Meets Cell Biology: Applications to Human Health and Disease (B3)
February 18 - 23, 2014
Taos, New Mexico, USA Parkinson’s Disease: Genetics, Mechanisms and Therapeutics (Q7)
March 2 - 7, 2014
Keystone, Colorado, USA Mobile Genetic Elements and Genome Evolution (C2)
March 9 - 14, 2014
Santa Fe, New Mexico, USA Exploiting and Understanding Chemical Biotransformations in the Human Microbiome (D1)
April 1 - 6, 2014
Big Sky, Montana, USA Epigenetic Programming and Inheritance (D2)
April 6 - 10, 2014
Boston, Massachusetts, USA  

Immunology

Advancing Vaccines in the Genomics Era (T1)
October 31 - November 4, 2013
Rio de Janeiro, Brazil The Ubiquitin System: From Basic Science to Drug Discovery (A2)
January 7 - 12, 2014
Big Sky, Montana, USA Tissue-Resident Memory T Cells (A4)
January 12 - 16, 2014
Snowbird, Utah, USA Emerging Cytokine Networks (J3)
January 17 - 22, 2014
Vancouver, British Columbia, Canada Inflammatory Diseases: Recent Advances in Basic and Translational Research and Therapeutic Treatments (J4)
January 17 - 22, 2014
Vancouver, British Columbia, Canada Pathogenesis of Respiratory Viruses (J5)
January 19 - 24, 2014
Keystone, Colorado, USA Innate Immunity to Viral Infections (J6)
January 19 - 24, 2014
Keystone, Colorado, USA New Frontiers in the Discovery and Treatment of Thrombosis (A6)
January 26 - 30, 2014
Keystone, Colorado, USA Mechanisms and Consequences of Invertebrate-Microbe Interactions (A7)
January 26 - 30, 2014
Tahoe City, California, USA The Science of Malaria Eradication (F1)
February 2 - 7, 2014
Merida, Yucatan, Mexico Molecular Cell Biology of Macrophages in Human Diseases (B2)
February 9 - 14, 2014
Santa Fe, New Mexico, USA Prophylactic and Therapeutic Antibodies (Q3)
February 9 - 14, 2014
Keystone, Colorado, USA Biology of B Cell Responses (Q4)
February 9 - 14, 2014
Keystone, Colorado, USA Inflammation, Infection and Cancer (X1)
March 9 - 14, 2014
Whistler, British Columbia, Canada Immune Evolution in Cancer (X2)
March 9 - 14, 2014
Whistler, British Columbia, Canada HIV Vaccines: Adaptive Immunity and Beyond (X3)
March 9 - 14, 2014
Banff, Alberta, Canada HIV Pathogenesis - Virus vs. Host (X4)
March 9 - 14, 2014
Banff, Alberta, Canada Fibrosis: From Bench to Bedside (C4)
March 23 - 28, 2014
Keystone, Colorado, USA Innate Immunity, Metabolism and Vascular Injury (X8)
March 23 - 28, 2014
Whistler, British Columbia, Canada Novel Therapeutic Approaches to Tuberculosis (C7)
March 30 - April 4, 2014
Keystone, Colorado, USA Exploiting and Understanding Chemical Biotransformations in the Human Microbiome (D1)
April 1 - 6, 2014
Big Sky, Montana, USA  

Infectious Diseases

Advancing Vaccines in the Genomics Era (T1)
October 31 - November 4, 2013
Rio de Janeiro, Brazil Pathogenesis of Respiratory Viruses (J5)
January 19 - 24, 2014
Keystone, Colorado, USA Innate Immunity to Viral Infections (J6)
January 19 - 24, 2014
Keystone, Colorado, USA Mechanisms and Consequences of Invertebrate-Microbe Interactions (A7)
January 26 - 30, 2014
Tahoe City, California, USA The Science of Malaria Eradication (F1)
February 2 - 7, 2014
Merida, Yucatan, Mexico Molecular Cell Biology of Macrophages in Human Diseases (B2)
February 9 - 14, 2014
Santa Fe, New Mexico, USA Prophylactic and Therapeutic Antibodies (Q3)
February 9 - 14, 2014
Keystone, Colorado, USA Mobile Genetic Elements and Genome Evolution (C2)
March 9 - 14, 2014
Santa Fe, New Mexico, USA Inflammation, Infection and Cancer (X1)
March 9 - 14, 2014
Whistler, British Columbia, Canada HIV Vaccines: Adaptive Immunity and Beyond (X3)
March 9 - 14, 2014
Banff, Alberta, Canada HIV Pathogenesis - Virus vs. Host (X4)
March 9 - 14, 2014
Banff, Alberta, Canada The Ins and Outs of Viral Infection: Entry, Assembly, Exit and Spread (C6)
March 30 - April 4, 2014
Breckenridge, Colorado, USA Novel Therapeutic Approaches to Tuberculosis (C7)
March 30 - April 4, 2014
Keystone, Colorado, USA  

Metabolic Diseases

Challenges and Opportunities in Diabetes Research and Treatment (J1)
January 12 - 17, 2014
Vancouver, British Columbia, Canada Obesity: A Multisystems Perspective (J2)
January 12 - 17, 2014
Vancouver, British Columbia, Canada Growth and Wasting in Heart and Skeletal Muscle (A8)
January 26 - 31, 2014
Santa Fe, New Mexico, USA Molecular Cell Biology of Macrophages in Human Diseases (B2)
February 9 - 14, 2014
Santa Fe, New Mexico, USA Mitochondrial Dynamics and Physiology (Q5)
February 18 - 23, 2014
Santa Fe, New Mexico, USA Metabolism and Angiogenesis (X5)
March 16 - 21, 2014
Whistler, British Columbia, Canada Tumor Metabolism (X6)
March 16 - 21, 2014
Whistler, British Columbia, Canada Lipid Pathways in Biology and Disease (C3)
March 19 - 24, 2014
Dublin 4, Ireland Complications of Diabetes (X7)
March 23 - 28, 2014
Whistler, British Columbia, Canada Innate Immunity, Metabolism and Vascular Injury (X8)
March 23 - 28, 2014
Whistler, British Columbia, Canada Exploiting and Understanding Chemical Biotransformations in the Human Microbiome (D1)
April 1 - 6, 2014
Big Sky, Montana, USA Emerging Concepts and Targets in Islet Biology (D3)
April 6 - 11, 2014
Keystone, Colorado, USA  

Neurobiology

Mitochondrial Dynamics and Physiology (Q5)
February 18 - 23, 2014
Santa Fe, New Mexico, USA Parkinson’s Disease: Genetics, Mechanisms and Therapeutics (Q7)
March 2 - 7, 2014
Keystone, Colorado, USA Alzheimer’s Disease – From Fundamental Insights to Light at the End of the Translational Tunnel (Q8)
March 2 - 7, 2014
Keystone, Colorado, USA Complications of Diabetes (X7)
March 23 - 28, 2014
Whistler, British Columbia, Canada Adult Neurogenesis (E1)
May 12 - 17, 2014
Stockholm, Sweden Autophagy: Fundamentals to Disease (E2)
May 23 - 28, 2014
Austin, TX, USA The Brain: Adaptation and Maladaptation in Chronic Pain (E3)
June 15 - 20, 2014
Keystone, Colorado, USA  

Plant Biology

Plant Signaling: Dynamic Properties (B1)
February 5 - 10, 2014
Breckenridge, Colorado, USA  

Structural Biology

The Ins and Outs of Viral Infection: Entry, Assembly, Exit and Spread (C6)
March 30 - April 4, 2014
Breckenridge, Colorado, USA G Protein-Coupled Receptors: Structural Dynamics and Functional Implications (Z1)
March 30 - April 4, 2014
Snowbird, Utah, USA Frontiers of Structural Biology (Z2)
March 30 - April 4, 2014
Snowbird, Utah, USA  

Technologies

Stem Cells and Cancer (J8)
February 2 - 7, 2014
Banff, Alberta, Canada Mobile Genetic Elements and Genome Evolution (C2)
March 9 - 14, 2014
Santa Fe, New Mexico, USA HIV Pathogenesis - Virus vs. Host (X4)
March 9 - 14, 2014
Banff, Alberta, Canada Emerging Concepts and Targets in Islet Biology (D3)
April 6 - 11, 2014
Keystone, Colorado, USA Adult Neurogenesis (E1)
May 12 - 17, 2014
Stockholm, Sweden